| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |